Pan-antiviral peptides
AssigneeNuovo Biologics, LLC
InventorsKent D. Miller, Billy S. Austin
Life of this patent
Estimating the term…
Abstract
Methods for preparing viral neuraminidase inhibitors including antiviral peptides by specifically chemically modifying disulfide bonds in precursor molecules. A method of inhibiting viral neuraminidases by administering a viral neuraminidase inhibitor comprising an antiviral peptide prepared by the above methods and inhibiting the viral neuraminidase. Therapeutics for inhibiting viral neuraminidases, including effective amounts of viral neuraminidase inhibitors including antiviral peptides derived from selectively chemically modified disuifide bonds in precursor molecules, and present in a pharmaceutically acceptable carriers.
Claims14
A method for preparing viral neuraminidase inhibitors comprising antiviral peptides including the step of specifically chemically modifying disulfide bonds in a precursor of viral neuraminidase.
A method of inhibiting viral neuraminidases, including the steps of:
- administering a viral neuraminidase inhibitor comprising an antiviral peptide prepared by specifically chemically modifying disulfide bonds in a precursor of viral neuraminidase,
- and inhibiting the viral neuraminidase.
A therapeutic for inhibiting viral neuraminidases and their derivatives comprising an effective amount of a viral neuraminidase inhibitor comprising an antiviral peptide derived from selectively chemically modifying disulfide bonds in a precursor of viral neuraminidase, in a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.